drugset / Trial / NCT06214481
A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants
NaSingle-groupOpen-labelBasic science
Summary
The primary objective of the study is to evaluate the pharmacokinetics of rocatinlimab after single subcutaneous (SC) administration in healthy Chinese participants.
Timeline
- Start
- 2024-01-23
- Primary completion
- 2024-05-27
- Completion
- 2024-06-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rocatinlimab | Monoclonal antibody | — | Subcutaneous |